LIPO - Lipella Pharmaceuticals Annual Revenue Growth (Last Twelve Months)

Graphic logo of Lipella Pharmaceuticals (LIPO)

Lipella Pharmaceuticals focuses on repurposing profitable urology drugs while facing binary risks associated with early-stage testing. The year-over-year sales growth percentage (over 4 quarters) illustrates the current trend, where 714.70 serves as the current parameter value. Business stability relies on a liposomal delivery platform for bladder agents and stringent patents within the cystitis treatment niche.

LIPO: Lipella Pharmaceuticals Sales Growth YoY (TTM) 02/11/2024 - 02/20/2024

Summary analytical data breakdowns for Lipella Pharmaceuticals, Inc. (LIPO)

- stock price and consensus target price:
Summary company analytics:LIPO (Lipella Pharmaceuticals)
Manufactured products of lipella.com

Lipella Pharmaceuticals (LIPO) is a biotech startup whose market capitalization is based on the prospects of bladder pathology therapies rather than current turnover. Analyzing the year-over-year sales trend over the last 12 months, an investor sees TTM revenue dynamics that measure operational growth rates relative to the previous year, which in this case confirms the absence of commercial sales prior to the completion of clinical trials.

Competitor analysis for Lipella Pharmaceuticals

Sales Growth YoY (TTM) Haleon Corp HLN|Kenvue Inc - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth veronapharma.com|Jyong Bio (MENS) - Sales Growth YoY (Last Twelve Months)|Revenue Growth Rate YoY (Last Twelve Months) Ligand LGND|AMRX (amneal.com) - Sales Growth YoY (TTM)|PRGO: Revenue Dynamics YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) ALVO (Alvotech Corp)|Annual Revenue Growth (Last Twelve Months) Liquidia Corporation|Sales Growth YoY (TTM) GLPG (glpg.com)|Revenue Dynamics YoY (Last Twelve Months) ANIP|MNKD - Sales Growth YoY (Last Twelve Months)|Amphastar - Revenue Change YoY (Last 12 Months)|PCRX: Sales Growth YoY (TTM)|ars-pharma.com - Revenue Dynamics YoY (Last Twelve Months)|TBPH (Theravance Biopharma Inc) - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Aquestive Pharma AQST|Sales Growth YoY (TTM) SCPH|Revenue Change YoY (Last 12 Months) TECX|Sales Growth YoY (Last Twelve Months) tonixpharma.com TNXP|SXTC (SXT China) - Trailing Twelve Months Sales Growth|Eupraxia Pharmaceuticals - Sales Growth YoY (TTM)|Annual Revenue Growth (Last Twelve Months) BioHarvest Sciences Inc. BHST|EXOZ: Sales Growth YoY (TTM)|Oramed (ORMP) - Sales Growth YoY (TTM)|ENTX (Entera Bio) - Sales Growth YoY (TTM)|ipatherapeutics.com (HYFT) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) ABVC|CPIX (Cumberland Pharmaceuticals Inc) - Revenue Dynamics YoY (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Quantum BioPharma Corp QNTM|FibroGen Corporation (FGEN) - Trailing Twelve Months Revenue Growth|TELO: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp (SNYR) - Sales Growth YoY (Last Twelve Months)|RLYB - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Lexaria Bioscience|Pulmatrix Corp - Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) ftzy.com.cn (PTHL)|Aptorum Group - Sales Growth YoY (Last 12 Months)|Sales Growth YoY (TTM) LYRA (Lyra Therapeutics Inc.)|Annual Revenue Growth (Last Twelve Months) Impact BioMedical (IBO)|TNF Pharmaceuticals - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth cbdMD Inc.|PainReform Ltd. (PRFX) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Altamira Therapeutics (CYTO)|Revenue Growth YoY (Last 12 Months) OPTN|Pieris Pharmaceuticals Inc (PIRS) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) PROC|PTPI: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) Qilian International QLI|Revenue Change YoY (Last 12 Months) SLRN (Acelyrin, Inc.)|TFFP - Sales Growth YoY (Last Twelve Months)